Within- and between-subject biological variation estimates for the enumeration of lymphocyte deep immunophenotyping and monocyte subsets.

IF 3.8 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Kai Guo, Xiaoran Feng, Lei Xu, Chenbin Li, Yating Ma, Mingting Peng
{"title":"Within- and between-subject biological variation estimates for the enumeration of lymphocyte deep immunophenotyping and monocyte subsets.","authors":"Kai Guo, Xiaoran Feng, Lei Xu, Chenbin Li, Yating Ma, Mingting Peng","doi":"10.1515/cclm-2024-0371","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to deliver biological variation (BV) estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping (memory T/B cells, regulatory T cells, etc.) and classical, intermediate, and nonclassical monocyte subsets based on the full spectrum flow cytometry (FS-FCM) and a Biological Variation Data Critical Appraisal Checklist (BIVAC) design.</p><p><strong>Methods: </strong>Samples were collected biweekly from 60 healthy Chinese adults over 10 consecutive two-week periods. Each sample was measured in duplicate within a single run for lymphocyte deep immunophenotyping and monocyte subset determination using FS-FCM, including the percentage (%) and absolute count (cells/μL). After trend adjustment, a Bayesian model was applied to deliver the within-subject BV (CV<sub>I</sub>) and between-subject BV (CV<sub>G</sub>) estimates with 95 % credibility intervals.</p><p><strong>Results: </strong>Enumeration (% and cells/μL) for 25 types of lymphocyte deep immunophenotyping and three types of monocyte subset percentages showed considerable variability in terms of CV<sub>I</sub> and CV<sub>G</sub>. CV<sub>I</sub> ranged from 4.23 to 47.47 %. Additionally, CV<sub>G</sub> ranged between 10.32 and 101.30 %, except for CD4<sup>+</sup> effector memory T cells re-expressing CD45RA. No significant differences were found between males and females for CV<sub>I</sub> and CV<sub>G</sub> estimates. Nevertheless, the CV<sub>G</sub>s of PD-1<sup>+</sup> T cells (%) may be higher in females than males. Based on the desired analytical performance specification, the maximum allowable imprecision immune parameter was the CD8<sup>+</sup>PD-1<sup>+</sup> T cell (cells/μL), with 23.7 %.</p><p><strong>Conclusions: </strong>This is the first study delivering BV estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping, along with classical, intermediate, and nonclassical monocyte subsets, using FS-FCM and adhering to the BIVAC design.</p>","PeriodicalId":10390,"journal":{"name":"Clinical chemistry and laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry and laboratory medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/cclm-2024-0371","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aimed to deliver biological variation (BV) estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping (memory T/B cells, regulatory T cells, etc.) and classical, intermediate, and nonclassical monocyte subsets based on the full spectrum flow cytometry (FS-FCM) and a Biological Variation Data Critical Appraisal Checklist (BIVAC) design.

Methods: Samples were collected biweekly from 60 healthy Chinese adults over 10 consecutive two-week periods. Each sample was measured in duplicate within a single run for lymphocyte deep immunophenotyping and monocyte subset determination using FS-FCM, including the percentage (%) and absolute count (cells/μL). After trend adjustment, a Bayesian model was applied to deliver the within-subject BV (CVI) and between-subject BV (CVG) estimates with 95 % credibility intervals.

Results: Enumeration (% and cells/μL) for 25 types of lymphocyte deep immunophenotyping and three types of monocyte subset percentages showed considerable variability in terms of CVI and CVG. CVI ranged from 4.23 to 47.47 %. Additionally, CVG ranged between 10.32 and 101.30 %, except for CD4+ effector memory T cells re-expressing CD45RA. No significant differences were found between males and females for CVI and CVG estimates. Nevertheless, the CVGs of PD-1+ T cells (%) may be higher in females than males. Based on the desired analytical performance specification, the maximum allowable imprecision immune parameter was the CD8+PD-1+ T cell (cells/μL), with 23.7 %.

Conclusions: This is the first study delivering BV estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping, along with classical, intermediate, and nonclassical monocyte subsets, using FS-FCM and adhering to the BIVAC design.

淋巴细胞深度免疫分型和单核细胞亚群计数的受试者内和受试者间生物变异估计值。
研究目的本研究旨在基于全谱流式细胞仪(FS-FCM)和生物变异数据关键评估检查表(BIVAC)设计,对25种接受深度免疫分型的淋巴细胞亚群(记忆T/B细胞、调节性T细胞等)以及经典、中间和非经典单核细胞亚群进行生物变异(BV)估算:在连续 10 个两周的时间内,每两周从 60 名健康的中国成年人身上采集一次样本。在一次运行中对每个样本进行重复测量,使用 FS-FCM 进行淋巴细胞深度免疫分型和单核细胞亚群测定,包括百分比(%)和绝对计数(细胞/μL)。经过趋势调整后,应用贝叶斯模型得出受试者内 BV(CVI)和受试者间 BV(CVG)估计值,可信区间为 95%:结果:25 种淋巴细胞深度免疫分型和 3 种单核细胞亚群百分比的计数(百分比和细胞/μL)在 CVI 和 CVG 方面显示出相当大的差异。CVI 从 4.23 % 到 47.47 % 不等。此外,除重新表达 CD45RA 的 CD4+ 效应记忆 T 细胞外,CVG 在 10.32% 到 101.30% 之间。男性和女性的 CVI 和 CVG 估计值没有明显差异。不过,女性 PD-1+ T 细胞的 CVG(%)可能高于男性。根据所需的分析性能指标,最大允许不精确免疫参数是 CD8+PD-1+ T 细胞(细胞/μL),为 23.7%:这是首次使用 FS-FCM 和 BIVAC 设计,对 25 种淋巴细胞亚群进行深度免疫分型,并对经典、中间和非经典单核细胞亚群进行 BV 估算的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry and laboratory medicine
Clinical chemistry and laboratory medicine 医学-医学实验技术
CiteScore
11.30
自引率
16.20%
发文量
306
审稿时长
3 months
期刊介绍: Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine. CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine. It is one of the leading journals in the field, with an impact factor over 3. CCLM is issued monthly, and it is published in print and electronically. CCLM is the official journal of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and publishes regularly EFLM recommendations and news. CCLM is the official journal of the National Societies from Austria (ÖGLMKC); Belgium (RBSLM); Germany (DGKL); Hungary (MLDT); Ireland (ACBI); Italy (SIBioC); Portugal (SPML); and Slovenia (SZKK); and it is affiliated to AACB (Australia) and SFBC (France). Topics: - clinical biochemistry - clinical genomics and molecular biology - clinical haematology and coagulation - clinical immunology and autoimmunity - clinical microbiology - drug monitoring and analysis - evaluation of diagnostic biomarkers - disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) - new reagents, instrumentation and technologies - new methodologies - reference materials and methods - reference values and decision limits - quality and safety in laboratory medicine - translational laboratory medicine - clinical metrology Follow @cclm_degruyter on Twitter!
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信